
Minerva Neurosciences, Inc. — Investor Relations & Filings
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-27 | English | |
| 424B5 | 2026-05-27 | English | |
| 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | |
| DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47845662 | 8-K | 2026-05-27 | English | ||
| 47845919 | 424B5 | 2026-05-27 | English | ||
| 41373781 | 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 41366414 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 35695380 | ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 35694016 | DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 33644856 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-06 | English | ||
| 32997937 | EFFECT - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-03-20 | English | ||
| 30823528 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823514 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823505 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 30823508 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 30823520 | 8-K Filing | 2026-02-03 | English | ||
| 12747695 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 12747696 | 424B3 | 2026-01-06 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alligator Bioscience
Clinical-stage biotech developing tumor-directed immuno-onc…
|
ATORX | SE | Manufacturing |
|
Allmed Medical Products Co., Ltd
Manufacturer of medical dressings, surgical kits, and dispo…
|
002950 | CN | Manufacturing |
|
Allogene Therapeutics, Inc.
Develops off-the-shelf allogeneic CAR T therapies for cance…
|
ALLO | US | Manufacturing |
|
Almirall S.A.
Global biopharmaceutical company specializing in medical de…
|
ALM | ES | Manufacturing |
|
ALNYLAM PHARMACEUTICALS, INC.
A biopharmaceutical company developing RNA interference (RN…
|
ALNY | US | Manufacturing |
|
Alpa Laboratories Limited
WHO-GMP certified manufacturer of human and veterinary phar…
|
ALPA | IN | Manufacturing |
|
Alpha Cognition Inc.
A biopharmaceutical company developing treatments for neuro…
|
ACOG | CA | Manufacturing |
|
Alphamab Oncology
Innovative biopharma specializing in differentiated anti-tu…
|
9966 | KY | Manufacturing |
|
Alpha Teknova, Inc.
Manufacturer of critical reagents for the life sciences ind…
|
TKNO | US | Manufacturing |
|
ALTERITY THERAPEUTICS LTD
A clinical-stage biotech developing novel treatments for ne…
|
ATHE | US | Manufacturing |
Minerva Neurosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Minerva Neurosciences, Inc. (id: 35086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.